Next Article in Journal
Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination
Next Article in Special Issue
Multidimensional Frailty and Vaccinations in Older People: A Cross-Sectional Study
Previous Article in Journal
Pivotal Shigella Vaccine Efficacy Trials—Study Design Considerations from a Shigella Vaccine Trial Design Working Group
Previous Article in Special Issue
The Implications of Vaccines in Older Populations
 
 
Article

Article Versions Notes

Vaccines 2022, 10(4), 490; https://doi.org/10.3390/vaccines10040490
Action Date Notes Link
article xml file uploaded 23 March 2022 04:16 CET Original file -
article xml uploaded. 23 March 2022 04:16 CET Update -
article pdf uploaded. 23 March 2022 04:16 CET Version of Record -
article html file updated 23 March 2022 04:18 CET Original file -
article xml file uploaded 23 March 2022 06:47 CET Update -
article xml uploaded. 23 March 2022 06:47 CET Update https://www.mdpi.com/2076-393X/10/4/490/xml
article pdf uploaded. 23 March 2022 06:47 CET Updated version of record https://www.mdpi.com/2076-393X/10/4/490/pdf
article html file updated 23 March 2022 06:48 CET Update -
article html file updated 1 August 2022 07:04 CEST Update https://www.mdpi.com/2076-393X/10/4/490/html
Back to TopTop